Related Experiment Videos
[Liver transplantation for fulminant hepatitis]
Toshihiko Ikegami1, Seiji Kawasaki
1First Department of Surgery, Shinshu University School of Medicine, Matsumoto, Japan.
Nihon Geka Gakkai Zasshi
|June 7, 2002
Summary
Liver transplantation offers a better survival rate for fulminant hepatic failure than conventional therapy. Early consideration for liver transplantation is recommended for patients with severe acute hepatitis or grade 2 hepatic encephalopathy.
Area of Science:
- Hepatology
- Transplantation Surgery
- Critical Care Medicine
Context:
- End-stage liver disease and fulminant hepatic failure are significant clinical challenges.
- Liver transplantation is an established treatment for end-stage liver disease in Japan.
- Fulminant hepatitis presents with urgency, often leading to cerebral edema or multiorgan failure before spontaneous liver regeneration.
Purpose:
- To discuss the indications, procedures, and outcomes of liver transplantation for fulminant hepatitis.
- To evaluate the effectiveness of liver transplantation in patients with fulminant hepatic failure.
- To provide recommendations for the timing of liver transplantation in severe acute hepatitis.
Summary:
- A retrospective analysis of 23 liver transplantations for fulminant hepatitis at Shinshu University was performed.
- The study included 22 living donor and 1 cadaveric donor liver transplants.
- The actuarial 5-year patient and graft survival rate was 85.4%.
Impact:
- Liver transplantation demonstrates superior outcomes compared to conventional therapies for fulminant hepatic failure.
- The findings support listing patients with fulminant hepatic failure for liver transplantation upon development of grade 2 hepatic encephalopathy.
- Early consideration of liver transplantation is crucial for severe acute hepatitis cases to improve patient survival.